Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
28.99
-2.89 (-9.07%)
At close: Apr 1, 2025, 4:00 PM
29.70
+0.71 (2.44%)
After-hours: Apr 1, 2025, 4:11 PM EDT

RGC Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019
Market Capitalization
37744300450--
Upgrade
Market Cap Growth
-85.42%-85.42%-33.42%---
Upgrade
Enterprise Value
37339284452--
Upgrade
Last Close Price
31.883.3623.0434.60--
Upgrade
PB Ratio
50.485.3225.0126.36--
Upgrade
P/TBV Ratio
5.325.3224.9226.39--
Upgrade
Debt / Equity Ratio
0.010.010.040.05-0.92-1.16
Upgrade
Quick Ratio
41.1341.1319.0628.420.010.12
Upgrade
Current Ratio
41.9241.9219.1528.460.020.12
Upgrade
Return on Equity (ROE)
-43.18%-43.18%-41.71%-116.10%--
Upgrade
Return on Assets (ROA)
-28.11%-28.11%-25.59%-51.87%-202.15%-134.09%
Upgrade
Return on Capital (ROIC)
-28.52%-28.52%-25.88%-54.30%-1670.73%-153.32%
Upgrade
Earnings Yield
-1.13%-9.84%-1.96%-1.65%--
Upgrade
FCF Yield
-1.05%-9.16%-1.66%-1.34%--
Upgrade
Buyback Yield / Dilution
--1.62%-28.06%--
Upgrade
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q